Spinraza: Interim Ph III data

The double-blind, international Phase III CHERISH trial in 126 non-ambulatory patients with later-onset SMA was stopped early after a pre-specified interim analysis showed that intrathecal Spinraza met the

Read the full 285 word article

User Sign In